{"id":"W2030458038","doi":"10.1007/s10227-005-0116-1","title":"Clinical Efficacy of Efalizumab in Patients With Chronic Plaque Psoriasis: Results From Three Randomized Placebo-Controlled Phase III Trials: Part I","year":2005,"lang":"en","type":"review","venue":"Journal of Cutaneous Medicine and Surgery","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":31,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Efalizumab; Medicine; Psoriasis; Psoriasis Area and Severity Index; Placebo; Adverse effect; Plaque psoriasis; Internal medicine; Randomized controlled trial; Dermatology; Severity of illness; Clinical trial; Gastroenterology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01195431,0.001860397,0.004870765,0.0007234953,0.0007604064,0.001900162,0.001509072,0.0029562,0.002494368],"category_scores_gemma":[0.009059154,0.0007802039,0.004461422,0.001420716,0.001711033,0.001160415,0.0004792362,0.002081554,0.0004796857],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00103378,"about_ca_system_score_gemma":0.001577141,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000768806,"about_ca_topic_score_gemma":0.001296239,"domain_scores_codex":[0.9955777,0.002675485,0.0006265516,0.0004627334,0.0004010338,0.0002565407],"domain_scores_gemma":[0.993597,0.002199848,0.002599253,0.0004675857,0.000438531,0.0006976913],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.8758228,0.007324126,0.005561472,0.006081481,0.01692116,0.00006068897,0.0001973456,0.0005554724,0.006852091,0.0001235075,0.001681625,0.07881831],"study_design_scores_gemma":[0.9060988,0.07119108,0.01245091,0.0003522164,0.007051776,0.0001061768,0.00004868877,0.0001781277,0.0008362236,0.0001759722,0.001479656,0.00003032932],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.7730979,0.204684,0.003632733,0.002149968,0.0007038628,0.01065629,0.002157896,0.000384026,0.002533536],"genre_scores_gemma":[0.9367393,0.04317873,0.004416688,0.002185965,0.0007400573,0.009925989,0.001976699,0.00005977763,0.0007767936],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.01195431,"threshold_uncertainty_score":0.06322116,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06949153664816805,"score_gpt":0.3514986361385988,"score_spread":0.2820070994904307,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}